These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7689807)

  • 1. Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.
    Abdulaziz L; Elhadi E; Abdallah EA; Alnoor FA; Yousef BA
    J Exp Pharmacol; 2022; 14():97-115. PubMed ID: 35299994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review.
    Long J; Ji W; Zhang D; Zhu Y; Bi Y
    Front Pharmacol; 2021; 12():759220. PubMed ID: 34721042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era.
    Napoli PE; Mangoni L; Gentile P; Braghiroli M; Fossarello M
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV replication in vitro by fusidic acid.
    Faber V; Dalgleish AG; Newell A; Malkovsky M
    Lancet; 1987 Oct; 2(8563):827-8. PubMed ID: 2443777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bile salts and of fusidic acid on HIV-1 infection of cultured cells.
    Lloyd G; Atkinson T; Sutton PM
    Lancet; 1988 Jun; 1(8600):1418-21. PubMed ID: 2898581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase fidelity and HIV-1 variation.
    Keulen W; Nijhuis M; Schuurman R; Berkhout B; Boucher C
    Science; 1997 Jan; 275(5297):229; author reply 230-1. PubMed ID: 8999550
    [No Abstract]   [Full Text] [Related]  

  • 7. Fusidic acid treatment of HIV infection: no significant effect in a pilot trial.
    Hørding M; Christensen KC; Faber V
    Scand J Infect Dis; 1990; 22(6):649-52. PubMed ID: 2284572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro efficacy of fusidic acid in HIV infection.
    Famularo G; De Simone C; Tzantzoglou S; Trinchieri V; Moretti S; Tonietti G
    Ann N Y Acad Sci; 1993 Jun; 685():341-3. PubMed ID: 7689807
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitors of HIV-1 reverse transcriptase.
    Ilina T; Parniak MA
    Adv Pharmacol; 2008; 56():121-67. PubMed ID: 18086411
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?
    Kilby JM; Saag MS
    Infect Agents Dis; 1994 Dec; 3(6):313-23. PubMed ID: 7534192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
    Winters MA; Merigan TC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2575-82. PubMed ID: 15980322
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.